112 related articles for article (PubMed ID: 23211696)
1. Mast cell sarcoma in an infant: a case report and review of the literature.
Bautista-Quach MA; Booth CL; Kheradpour A; Zuppan CW; Rowsell EH; Weiss L; Wang J
J Pediatr Hematol Oncol; 2013 May; 35(4):315-20. PubMed ID: 23211696
[TBL] [Abstract][Full Text] [Related]
2. Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?
Falleti J; Borgia L; Lalinga AV; De Cecio R; Natella V; Patitucci G; Vita G
Pathol Res Pract; 2012 Nov; 208(11):683-6. PubMed ID: 22963840
[TBL] [Abstract][Full Text] [Related]
3. Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm.
Kim YS; Wu H; Pawlowska AB; Bautista-Quach MA; Huang Q; Gaal K; Chang KL
Am J Surg Pathol; 2013 Mar; 37(3):453-8. PubMed ID: 23388130
[TBL] [Abstract][Full Text] [Related]
4. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma.
Auquit-Auckbur I; Lazar C; Deneuve S; Guillemet C; Cordel N; Blanchard F; Joly P; Courville P
Am J Surg Pathol; 2012 May; 36(5):779-82. PubMed ID: 22498828
[TBL] [Abstract][Full Text] [Related]
6. Mast cell sarcoma: new cases and literature review.
Monnier J; Georgin-Lavialle S; Canioni D; Lhermitte L; Soussan M; Arock M; Bruneau J; Dubreuil P; Bodemer C; Chandesris MO; Lortholary O; Hermine O; Damaj G
Oncotarget; 2016 Oct; 7(40):66299-66309. PubMed ID: 27602777
[TBL] [Abstract][Full Text] [Related]
7. Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature.
Georgin-Lavialle S; Aguilar C; Guieze R; Lhermitte L; Bruneau J; Fraitag S; Canioni D; Chandesris MO; Suarez F; Grandpeix-Guyodo C; Damaj G; Barete S; Aouba A; Fite C; Robert C; Gaulard P; Lortholary O; Tournilhac O; Dubreuil P; Hermine O
J Clin Oncol; 2013 Feb; 31(6):e90-7. PubMed ID: 23129735
[No Abstract] [Full Text] [Related]
8. Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma.
Chott A; Guenther P; Huebner A; Selzer E; Parwaresch RM; Horny HP; Valent P
Am J Surg Pathol; 2003 Jul; 27(7):1013-9. PubMed ID: 12826896
[TBL] [Abstract][Full Text] [Related]
9. Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature.
Matsumoto NP; Yuan J; Wang J; Shen Q; Chen X; Kim Y; Zuppan CW; Chang CC; Cui W; Chen D; Shi M; Gisriel SD; Chen M; Xu ML; Pan Z
Mod Pathol; 2022 Jul; 35(7):865-874. PubMed ID: 35105959
[TBL] [Abstract][Full Text] [Related]
10. Biology, classification and treatment of human mastocytosis.
Valent P
Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
[TBL] [Abstract][Full Text] [Related]
11. Case report of a clinically indolent but morphologically high-grade cutaneous mast cell tumor in an adult: Atypical cutaneous mastocytoma or mast cell sarcoma?
Wardle CLW; Oldhoff JM; Diepstra A; Valent P; Horny HP; Oude Elberink HNG; Kluin PM; Diercks GFH
J Cutan Pathol; 2021 Nov; 48(11):1404-1409. PubMed ID: 34152029
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells.
Gleixner KV; Rebuzzi L; Mayerhofer M; Gruze A; Hadzijusufovic E; Sonneck K; Vales A; Kneidinger M; Samorapoompichit P; Thaiwong T; Pickl WF; Yuzbasiyan-Gurkan V; Sillaber C; Willmann M; Valent P
Exp Hematol; 2007 Oct; 35(10):1510-21. PubMed ID: 17681669
[TBL] [Abstract][Full Text] [Related]
15. Tissue mast cells in health and disease.
Parwaresch MR; Horny HP; Lennert K
Pathol Res Pract; 1985 Mar; 179(4-5):439-61. PubMed ID: 2582403
[TBL] [Abstract][Full Text] [Related]
16. Solitary mastocytoma in an infant - case report with review of literature.
Kacker A; Huo J; Huang R; Hoda RS
Int J Pediatr Otorhinolaryngol; 2000 Jan; 52(1):93-5. PubMed ID: 10699246
[TBL] [Abstract][Full Text] [Related]
17. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
18. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
[TBL] [Abstract][Full Text] [Related]
19. Mastocytosis.
Metcalfe DD
Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].
Sotlar K
Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
